Company profile
CSPC Pharmaceutical Group
Diversified pharma
Public Market Listing
1093HKEX
Live quotes, historical charts, and market capitalization for CSPC Pharmaceutical Group are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(11 total)
11Total Assets
0Approved
9Phase 3 / Filed
2Phase 1–2 / Early
9Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Phase 3 | Serotonin/norepinephrine transporterSmall molecule | Major Depressive Disorder | |
DBPR108No recent activity | Phase 3 | DPP-4Small molecule | Type 2 Diabetes |
| Phase 3 | HER2 (biparatopic — extracellular domains II and IV)Antibody–drug conjugate | HR+/HER2- Breast Cancer HR+/HER2- Metastatic Breast Cancer | |
| Phase 3 | Dopamine D2 and serotonin 5-HT2A receptors (antagonist)Small molecule | Schizophrenia | |
| Phase 3 | FLT3 / EGFR / ABL (also Fyn, Hck, Lck, Lyn, Ret, Yes)Small molecule | Acute Myeloid Leukemia | |
| Phase 3 | PCSK9Monoclonal antibody | Atherosclerotic Cardiovascular Disease | |
| Phase 3 | Angiotensin II type 1 receptor / L-type calcium channel (dual)Small molecule | Hypertension | |
| Phase 3 | TYK2Small molecule | Psoriasis | |
| Phase 3 | GLP-1 receptorPeptide | Obesity | |
| Phase 2 | LPA gene / apolipoprotein(a)RNA / oligonucleotide | Atherosclerotic Cardiovascular Disease | |
| Phase 2 | ANGPTL3RNA / oligonucleotide | Atherosclerotic Cardiovascular Disease |
Upcoming events
Research
Sign in to access ResearchUnlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Sign in to access ResearchUnlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.